Details for Patent: 11,890,270
✉ Email this page to a colleague
Which drugs does patent 11,890,270 protect, and when does it expire?
Patent 11,890,270 protects TPOXX and is included in one NDA.
This patent has thirty-eight patent family members in twenty countries.
Drugs Protected by US Patent 11,890,270
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Siga Technologies | TPOXX | tecovirimat | CAPSULE;ORAL | 208627-001 | Jul 13, 2018 | RX | Yes | Yes | 11,890,270 | ⤷ Subscribe | TREATMENT OF HUMAN SMALLPOX DISEASE CAUSED BY VARIOLA VIRUS IN ADULTS AND PEDIATRIC PATIENTS WEIGHING AT LEAST 13 KG | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,890,270
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2549871 | ⤷ Subscribe | 122022000033 | Germany | ⤷ Subscribe |
| European Patent Office | 2549871 | ⤷ Subscribe | 22C1023 | France | ⤷ Subscribe |
| African Regional IP Organization (ARIPO) | 3221 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
